$ Value
$0
Shares
961,700
Price
$0
Filed
Feb 6
Insider
Name
Walker Neal
Title
CEO
CIK
0001604457
Roles
Transaction Details
Transaction Date
2026-02-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
961,700
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. | Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Filing Info
Walker Neal's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | ACRS | M | — |
| 2026-02-03 | ACRS | F | $65K |
| 2026-02-03 | ACRS | M | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-01-02 | ACRS | M | — |
| 2026-01-02 | ACRS | F | $29K |
| 2026-01-02 | ACRS | M | $0 |
| 2025-06-10 | ALDX | A | $0 |
| 2025-06-10 | ALDX | A | $0 |
Other Insiders at ACRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walker Neal
CEO
|
— | — | 2026-02-03 |
|
Loerop James
Chief Business Officer
|
— | — | 2026-02-03 |
|
Balthaser Kevin
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Davis Hugh M.
President and COO
|
— | — | 2026-02-03 |
|
Hall Jesse Wayne
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Kolbeck Roland Wilhelm
Chief Scientific Officer
|
— | — | 2026-02-02 |